Heart failure with preserved ejection fraction: current understandings and challenges (Q38217344)

31 August 2017

title

Heart failure with preserved ejection fraction: current understandings and challenges (English)

1 reference

Heart failure with preserved ejection fraction

31 August 2017

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24893938%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Barry A Borlaug

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24893938%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Mads J Andersen

series ordinal

1

1 reference

31 August 2017

Barry A Borlaug

series ordinal

2

1 reference

31 August 2017

publication date

1 July 2014

1 reference

Current cardiology reports

31 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24893938%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24893938%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24893938%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

501

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24893938%20AND%20SRC:MED&resulttype=core&format=json

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Outcome of heart failure with preserved ejection fraction in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Importance of dynamic dyssynchrony in the occurrence of hypertensive heart failure with normal ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Right heart dysfunction in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Longitudinal changes in left ventricular stiffness: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Why are women more likely than men to develop heart failure with preserved ejection fraction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Obesity and severe obesity forecasts through 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Trends in blood pressure and hypertension detection, treatment, and control 1980 to 2009: the Minnesota Heart Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Cardiovascular Effects of 1 Year of Progressive and Vigorous Exercise Training in Previously Sedentary Individuals Older Than 65 Years of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Mechanisms of diastolic dysfunction in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Determinants of left ventricular early-diastolic lengthening velocity: independent contributions from left ventricular relaxation, restoring forces, and lengthening load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Loss of adrenergic augmentation of diastolic intra-LV pressure difference in patients with diastolic dysfunction: evaluation by color M-mode echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Role of left ventricular stiffness in heart failure with normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Congestive heart failure with preserved ejection fraction is associated with severely impaired dynamic Starling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Relationships between right ventricular function, body composition, and prognosis in advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Ventricular-vascular interaction in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Bedside assessment of cardiac hemodynamics: the impact of noninvasive testing and examiner experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Noninvasive evaluation of hemodynamics by Doppler echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Exercise-induced changes in left ventricular filling pressure after myocardial infarction assessed with simultaneous right heart catheterization and Doppler echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Echocardiographic indices do not reliably track changes in left-sided filling pressure in healthy subjects or patients with heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Irbesartan in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

The breathing heart - mitochondrial respiratory chain dysfunction in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-014-0501-8

Progression of left ventricular diastolic dysfunction and risk of heart failure

21 January 2018

1 reference

12 December 2020

Coronary artery disease in patients with heart failure and preserved systolic function

1 reference

12 December 2020

Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations

1 reference

12 December 2020

Mechanisms of exercise intolerance in heart failure with preserved ejection fraction

1 reference

12 December 2020

Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study

1 reference

12 December 2020

Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial

1 reference

12 December 2020

Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure

1 reference

12 December 2020

Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism

1 reference

12 December 2020

Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction

1 reference

12 December 2020

Cardiomyocyte Stiffness in Diastolic Heart Failure

1 reference

12 December 2020

Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction

1 reference

12 December 2020

Effect of aging and physical activity on left ventricular compliance

1 reference

12 December 2020

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

12 December 2020

Echocardiographic evaluation of diastolic function can be used to guide clinical care

1 reference

12 December 2020

Heart failure with preserved ejection fraction: treat now by treating comorbidities

1 reference

12 December 2020

Mechanism of augmented rate of left ventricular filling during exercise

1 reference

12 December 2020

Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction

1 reference

12 December 2020

Influence of coronary occlusion during PTCA on end-systolic and end-diastolic pressure-volume relations in humans

1 reference

12 December 2020

Impact of arterial load and loading sequence on left ventricular tissue velocities in humans

1 reference

12 December 2020

Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest

1 reference

12 December 2020

Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients

1 reference

12 December 2020

Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study

1 reference

12 December 2020

Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study

1 reference

12 December 2020

Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures

1 reference

12 December 2020

Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle

1 reference

12 December 2020

10.1007/S11886-014-0501-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24893938%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 June 2020

1035015869

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24893938%20AND%20SRC:MED&resulttype=core&format=json